Status Plus

Sponsored Sessions

Sponsored Sessions

Thursday, March 1, 2018

07:30 a.m. – 08:30 a.m.

Sponsored breakfast symposium – New perspectives in testosterone therapy: What is more important? Short-term sexual improvements or long-term benefits?

Location: Auditorium II
Sponsored by Bayer
Chair: Dr. Michael Zitzmann
Testosterone therapy in men with type 2 diabetes, sexual function, quality of life and mortality

Dr. Geoff Hackett

Update on hypogonadism and cardiovascular risk

Dr. Giovanni Corona

Importance of long-term treatment to achieve full benefits of testosterone therapy

Dr. David Edwards

10:30 a.m. -12:30 p.m.

Live surgery session

Broadcasted from Centro Hospital Lisboa Norte
(Hospital Santa Maria)
Location: Auditorium I
Sponsored by Boston Scientific
Chair: Carlo Bettocchi
Live surgery:
AMS™ 700

Dr. Juan Ingnacio Martinez-Salamanca, Madrid, Spain

Semi Live:
AMS 700 with male sling

Dr. Brian Christine, Birmingham Alabama, USA

Sub Coronal IPP under local anaesthesia

Dr. Sean Park – Seoul, South Korea

03:00 p.m. – 03:30 p.m.

Sponsored session – Treating ED: the expert’s 2.0 challenge

Location: Auditorium I
Sponsored by Menarini Group
20 years of PDE5-Is, the successes and the areas of amelioration

Prof. Emmanuele A. Jannini (chairman and speaker)

Avanafil in ED 2.0 management: the expert focus on clinical advantages

Prof. Irwin Goldstein (speaker)

Q&A and closing remarks

Prof. E.A. Jannini and Prof. I. Goldstein

04:30 p.m. – 05:30 p.m.

Industry innovation platform

Location: Auditorium I
Moderator: Maarten Albersen, KU Leuven
The purpose of the forum is to provide a glimpse of the future, and examples of how technology will impact the practice of Sexual Medicine in the next several years. Leaders from the companies that have agreed to participate will deliver a short presentation
about the vision of their organization, followed by a panel discussion with the moderators and questions from the audience.

Jeannette Bankes, Boston Scientific
David Perry, Urotronic
Trinity Bivalacqua, Tissue Genesis
Moshe Ein-Gal, The Direx Group

Friday, March 2, 2018

11:30 a.m. – 12:30 p.m.

Spotlight discussion session

Location: Auditorium II
Sponsored by GlaxoSmithKline
Chair: Juan Manuel Palacios, PhD. Scientific Director, Global Urology, GlaxoSmithKline

Michael J. Manyak, MD, FACS. Global Medical Affairs Director Urology, GlaxoSmithKline
Prof. François Giuliano, MD, PhD, Department of Physical Medicine and Rehabilitation Raymond Poincaré Hal Garches, Versailles Saint Quentin University, France
Alejandro Carvajal Obando, MD. Associate Professor, CES University, Medellin, Colombia
Juan Ignacio Martínez-Salamanca, MD. University Hospital Puerta de Hierro, Madrid, Spain

11.30 a.m. – 11.35 a.m.

Welcome and introduction

Juan Manuel Palacios

11.35 a.m. – 11.50 a.m.

How do we currently interpret the safety profile of 5-ARI + α blocker therapies from RCTs?

François Giuliano

11.50 a.m. – 12.05 p.m.

Impact of BPH treatment on sexual function: what’s new?

Michael J. Manyak

12.05 p.m. – 12.25 p.m.

Expert insights into sexual function in BPH patients treated with 5 ARI + α blockers: panel discussion and Q&A

Chair: Juan Manuel Palacios
Panellists: François Giuliano, Michael J. Manyak, Alejandro Carvajal Obando, & Juan Ignacio Martínez-Salamanca

12.25 p.m. – 12.30 p.m.

Closing remarks

Juan Manuel Palacios

12:45 p.m. – 01:45 p.m.

Live lunch time symposium – A patients journey

Location: Room 5 B/C in Pavilion 5
Sponsored by Boston Scientific

Patient: John Goodridge
Mr. David Ralph, Consultant Andrologist UCLH London, United Kingdom
Mr. Kamm Mann, Primary Care Physician, Winchester, United Kingdom

Saturday, March 3, 2018

09:00 a.m. – 11:00 a.m.

Nurse training session – The patients journey through erectile restoration

Location: Room 5 A in Pavilion 5
Sponsored by Boston Scientific

Pedro Vendeira MD, PhD, FECSM, President of the Portuguese Society of Andrology, Sexual Medicine and Reproduction, Oporto, Portugal
Professor Nuno Tomada Reconstructive Urologist, Faculdade de Medicina do Porto, Portugal